<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03937375</url>
  </required_header>
  <id_info>
    <org_study_id>REPEAT</org_study_id>
    <nct_id>NCT03937375</nct_id>
  </id_info>
  <brief_title>Re-Evaluation of the Effects of High PEEP During General Anesthesia For Surgery (REPEAT)</brief_title>
  <acronym>REPEAT</acronym>
  <official_title>Re-Evaluation of the Effects of High PEEP During General Anesthesia For Surgery - An Individual Patient Data Meta-Analysis of PROVHILO, iPROVE and PROBESE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Israelita Albert Einstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Carl Gustav Carus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Clínico Universitario de Valencia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Israelita Albert Einstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aiming to understand the isolated impact of high PEEP in patients undergoing mechanical
      ventilation for general anesthesia for surgery, three appropriately sized international
      multicentre randomized controlled trials have been performed over recent years: the
      'PROtective Ventilation using HIgh versus LOw PEEP trial (PROVHILO), the 'individualized
      PeRioperative Open-lung Ventilation trial' (iPROVE), and the 'Protective intraoperative
      ventilation with higher versus lower levels of positive end-expiratory pressure in obese
      patients trial' (PROBESE). These three trials had several similarities in key areas of their
      study protocols, inclusion and exclusion criteria, and collected data, and even the primary
      and secondary outcomes. Of note, the three trials combined high PEEP with recruitment
      manoeuvres. This allows an individual patient data meta-analysis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postoperative pulmonary complications</measure>
    <time_frame>Until day seven or hospital discharge, whichever comes first</time_frame>
    <description>Collapsed composite of complications developing within the first seven postoperative days, including: Mild respiratory failure; or Severe respiratory failure; or Acute Respiratory Distress Syndrome (ARDS); or Pulmonary infection; or Pleural effusion; or Atelectasis; or Pneumothorax; or Bronchospasm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of severe postoperative pulmonary complications</measure>
    <time_frame>Until day seven or hospital discharge, whichever comes first</time_frame>
    <description>Collapsed composite of complications developing within the first seven postoperative days, including: Severe respiratory failure; or Acute Respiratory Distress Syndrome (ARDS); or Pulmonary infection; or Pleural effusion; or Atelectasis; or Pneumothorax; or Bronchospasm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of extrapulmonary pulmonary complications</measure>
    <time_frame>Until day seven or hospital discharge, whichever comes first</time_frame>
    <description>Collapsed composite of complications developing within the first seven postoperative days, including: Systemic Response Inflammatory Syndrome; or Sepsis; or Septic Shock; or Acute Kidney Injury.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of intraoperative complications</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Defined as intraoperative hypotension; or need for rescue for desaturations; or need for vasoactive drugs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of intensive care unit admission</measure>
    <time_frame>Until hospital discharge, death or 100 days, whichever comes first</time_frame>
    <description>Incidence of intensive care unit admission during hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>Until hospital discharge, death or 100 days, whichever comes first</time_frame>
    <description>Duration of hospital length of stay in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of 7-day mortality</measure>
    <time_frame>Until day seven or hospital discharge, whichever comes first</time_frame>
    <description>Mortality during the first seven days of hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of in-hospital mortality</measure>
    <time_frame>Until hospital discharge, death or 100 days, whichever comes first</time_frame>
    <description>Mortality during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major postoperative complications</measure>
    <time_frame>Until day seven or hospital discharge, whichever comes first</time_frame>
    <description>Collapsed composite of complications developing within the first seven postoperative combining severe postoperative pulmonary complications, sepsis, septic shock and/or acute kidney injury)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3837</enrollment>
  <condition>Surgery</condition>
  <condition>Mechanical Ventilation Complication</condition>
  <condition>Pulmonary Complication</condition>
  <arm_group>
    <arm_group_label>High PEEP</arm_group_label>
    <description>Use of high levels of PEEP with recruitment maneuvers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low PEEP</arm_group_label>
    <description>Use of low levels of PEEP without recruitment maneuvers</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High PEEP</intervention_name>
    <description>Use of high levels of PEEP combined with recruitment maneuvers and low tidal volume ventilation during general anesthesia</description>
    <arm_group_label>High PEEP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low PEEP</intervention_name>
    <description>Use of low levels of PEEP without recruitment maneuvers and low tidal volume ventilation during general anesthesia</description>
    <arm_group_label>Low PEEP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing mechanical ventilation for general anesthesia for surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Enrolled into one of the three studies (PROVHILO, iPROVE or PROBESE) to either high PEEP
        or low PEEP
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ary Serpa Neto, MD, MSc, PhD</last_name>
    <phone>+55 11 2151 1521</phone>
    <email>ary.neto2@einstein.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Niklas S Campos, MD</last_name>
    <phone>+55 11 2151 1521</phone>
    <email>niklas.soderberg@einstein.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Carl Gustav Carus, Technische Universität Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcelo Gama de Abreu, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Thomas Bluth</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amsterdam UMC, University of Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus J Schultz, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sabrine NT Hemmes</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Ferrando, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Julian Librero</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natividad Pozo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Hemmes SN, Severgnini P, Jaber S, Canet J, Wrigge H, Hiesmayr M, Tschernko EM, Hollmann MW, Binnekade JM, Hedenstierna G, Putensen C, de Abreu MG, Pelosi P, Schultz MJ. Rationale and study design of PROVHILO - a worldwide multicenter randomized controlled trial on protective ventilation during general anesthesia for open abdominal surgery. Trials. 2011 May 6;12:111. doi: 10.1186/1745-6215-12-111.</citation>
    <PMID>21548927</PMID>
  </reference>
  <reference>
    <citation>PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology, Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014 Aug 9;384(9942):495-503. doi: 10.1016/S0140-6736(14)60416-5. Epub 2014 Jun 2.</citation>
    <PMID>24894577</PMID>
  </reference>
  <reference>
    <citation>Ferrando C, Soro M, Canet J, Unzueta MC, Suárez F, Librero J, Peiró S, Llombart A, Delgado C, León I, Rovira L, Ramasco F, Granell M, Aldecoa C, Diaz O, Balust J, Garutti I, de la Matta M, Pensado A, Gonzalez R, Durán ME, Gallego L, Del Valle SG, Redondo FJ, Diaz P, Pestaña D, Rodríguez A, Aguirre J, García JM, García J, Espinosa E, Charco P, Navarro J, Rodríguez C, Tusman G, Belda FJ; iPROVE investigators (Appendices 1 and 2). Rationale and study design for an individualized perioperative open lung ventilatory strategy (iPROVE): study protocol for a randomized controlled trial. Trials. 2015 Apr 27;16:193. doi: 10.1186/s13063-015-0694-1.</citation>
    <PMID>25927183</PMID>
  </reference>
  <reference>
    <citation>Ferrando C, Soro M, Unzueta C, Suarez-Sipmann F, Canet J, Librero J, Pozo N, Peiró S, Llombart A, León I, India I, Aldecoa C, Díaz-Cambronero O, Pestaña D, Redondo FJ, Garutti I, Balust J, García JI, Ibáñez M, Granell M, Rodríguez A, Gallego L, de la Matta M, Gonzalez R, Brunelli A, García J, Rovira L, Barrios F, Torres V, Hernández S, Gracia E, Giné M, García M, García N, Miguel L, Sánchez S, Piñeiro P, Pujol R, García-Del-Valle S, Valdivia J, Hernández MJ, Padrón O, Colás A, Puig J, Azparren G, Tusman G, Villar J, Belda J; Individualized PeRioperative Open-lung VEntilation (iPROVE) Network. Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial. Lancet Respir Med. 2018 Mar;6(3):193-203. doi: 10.1016/S2213-2600(18)30024-9. Epub 2018 Jan 19.</citation>
    <PMID>29371130</PMID>
  </reference>
  <reference>
    <citation>Bluth T, Teichmann R, Kiss T, Bobek I, Canet J, Cinnella G, De Baerdemaeker L, Gregoretti C, Hedenstierna G, Hemmes SN, Hiesmayr M, Hollmann MW, Jaber S, Laffey JG, Licker MJ, Markstaller K, Matot I, Müller G, Mills GH, Mulier JP, Putensen C, Rossaint R, Schmitt J, Senturk M, Serpa Neto A, Severgnini P, Sprung J, Vidal Melo MF, Wrigge H, Schultz MJ, Pelosi P, Gama de Abreu M; PROBESE investigators; PROtective VEntilation Network (PROVEnet); Clinical Trial Network of the European Society of Anaesthesiology (ESA). Protective intraoperative ventilation with higher versus lower levels of positive end-expiratory pressure in obese patients (PROBESE): study protocol for a randomized controlled trial. Trials. 2017 Apr 28;18(1):202. doi: 10.1186/s13063-017-1929-0. Erratum in: Trials. 2017 Jun 1;18(1):247.</citation>
    <PMID>28454590</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>May 2, 2019</study_first_submitted>
  <study_first_submitted_qc>May 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2019</study_first_posted>
  <last_update_submitted>May 29, 2019</last_update_submitted>
  <last_update_submitted_qc>May 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Surgery</keyword>
  <keyword>Mechanical ventilation</keyword>
  <keyword>PEEP</keyword>
  <keyword>Postoperative pulmonary complications</keyword>
  <keyword>Individual patient data meta-analysis</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The harmonized dataset will be available after the publication of the main results and under request to the steering committee</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>After the publication of the main results</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

